Fame and future of faecal transplantations – developing next‐generation therapies with synthetic microbiomes
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Summary: While practised for over thousand years, there is presently a renaissance in the interest of using of faecal transplantations to modify the intestinal microbiota of patients. This clinical practice consists of delivering large amounts of bowel microbes in various forms into the intestinal tract of the recipient that usually has been cleared previously. The major reason for the popularity of faecal transplantations is their effectiveness in treating a variety of diseases. Hence, there is a need to develop this procedure to the next level. While there are various developments to select, standardize and store the donor microbiota, it is more challenging to understand the intestinal microbial communities and develop ways to deliver these via robust biotechnological processes. The various approaches that have been followed to do so are discussed in this contribution that is also addressing the concept of the minimal microbiome as well as the production of the synthetic communities that can be instrumental in new therapeutic avenues to modify the intestinal microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 5×
“In another study in the Amsterdam Medical Centre, a three-arm study was set up where 42 recurrent CDI patients either received vancomycin, vancomycin and a bowel lavage, or all these treatments followed by duodenal infusion of healthy donor faeces (van Nood et al., 2013).”
BackgroundInfluentialVrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Moving pictures of the human microbiome
Caporaso, J. G., Lauber, C. L., Costello, E. K., Berg-Lyons, D., Gonzalez, A., Stombaugh, J., Knights, D., Gajer, P., Ravel, J., Fierer, N., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-5-r50 · Cited by 1,138 · cited 1×
“A deeply sampled longitudinal study of two subjects for over a year showed the microbial composition in faecal samples to be rather stable in contrast to that in other body parts, such as skin and oral cavity (Caporaso et al., 2011).”
BackgroundRajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
The human gut virome: inter-individual variation and dynamic response to diet
Minot, S., Sinha, R., Chen, J., Li, H., Keilbaugh, S. A., Wu, G. D., Lewis, J. D., & Bushman, F. D. (2011) · Genome Research · doi:10.1101/gr.122705.111 · Cited by 935 · cited 1×
“Apart from CDI and UC, these include irritable bowel syndrome (IBS) that is also characterized by an aberrant microbial composition (Rajilic´-Stojanovicét al., 2011).”
BackgroundPetrof, E. O., Gloor, G. B., Vanner, S. J., Weese, S. J., Carter, D., Daigneault, M. C., Brown, E. M., Schroeter, K., & Allen-Vercoe, E. (2013) · Microbiome · doi:10.1186/2049-2618-1-3 · Cited by 731
Fecal microbiota transplantation and emerging applications
Borody, T. J., & Khoruts, A. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.244 · Cited by 677 · cited 1×
“Since then, many applications in CDI, UC and others have been pioneered, mostly as case studies (Borody and Khoruts, 2011).”
BackgroundKhoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181c87e02 · Cited by 649 · cited 3×
“This analysis extended previous studies in a single (Khoruts et al., 2010) or limited number of subjects with fresh (Shahinas et al.”
ResultShould we standardize the 1,700-year-old fecal microbiota transplantation?
Zhang, F., Luo, W., Shi, Y., Fan, Z., & Ji, G. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.251 · Cited by 619 · cited 3×
“Similarly, during the Ming dynasty (16th century) Li Shizen provided detailed descriptions of faecal therapies for the effective treatment of certain abdominal diseases, as noted recently (Zhang et al., 2012).”
BackgroundInfluentialDiversity of the human gastrointestinal tract microbiota revisited
Rajilić‐Stojanović, M., Smidt, H., & De Vos, W. M. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01369.x · Cited by 559
Cited by
Rivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,726
Engineering Microbiomes to Improve Plant and Animal Health
Mueller, U. G., & Sachs, J. L. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.07.009 · Cited by 628
Durable coexistence of donor and recipient strains after fecal microbiota transplantation
Li, S. S., Zhu, A., Benes, V., Costea, P. I., Hercog, R., Hildebrand, F., Huerta-Cepas, J., Nieuwdorp, M., Salojärvi, J., Voigt, A. Y., et al. (2016) · Science · doi:10.1126/science.aad8852 · Cited by 547
Self-citationMicrobially Mediated Plant Salt Tolerance and Microbiome-based Solutions for Saline Agriculture
Qin, Y., Druzhinina, I. S., Pan, X., & Yuan, Z. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.005 · Cited by 407
Coral microbiome dynamics, functions and design in a changing world
van Oppen, M. J. H., & Blackall, L. L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0223-4 · Cited by 403
Metadata
- Authors
- de Vos, W. M.
- Venue
- Microbial Biotechnology
- Publisher
- Wiley
- Published
- 2013-04-10
- Volume
- 6
- Issue
- 4
- Pages
- 316-325
- ISSN
- 1751-7915 (ISSN-L)
- OpenAlex
- W2164859403
- Cited by
- 80
- References
- 27
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fame and future of faecal transplantations – developing next‐generation therapies with synthetic microbiomes. https://app.cochat.ai/papers/10.1111/1751-7915.12047
- The paper
- de Vos, W. M. (2013). Fame and future of faecal transplantations – developing next‐generation therapies with synthetic microbiomes. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.12047
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.